FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35612411000001101: Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Aug 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
107893601000001110 Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
107893701000001117 Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Is a Irinotecan true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Is a Product containing irinotecan false Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Has active ingredient Irinotecan false Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Has dispensed dose form Infusion true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Is a True Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags 1 bag Has VMP True Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start